Tudor Investment Corp’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,628
Closed -$205K 1535
2025
Q1
$205K Sell
13,628
-22,361
-62% -$336K ﹤0.01% 1405
2024
Q4
$592K Buy
35,989
+6,647
+23% +$109K ﹤0.01% 1171
2024
Q3
$725K Buy
29,342
+715
+2% +$17.7K ﹤0.01% 1120
2024
Q2
$725K Sell
28,627
-7,420
-21% -$188K ﹤0.01% 1089
2024
Q1
$916K Buy
36,047
+11,686
+48% +$297K 0.01% 913
2023
Q4
$552K Sell
24,361
-11,670
-32% -$264K ﹤0.01% 1113
2023
Q3
$671K Buy
+36,031
New +$671K 0.01% 1036
2021
Q2
Sell
-33,185
Closed -$1.35M 1471
2021
Q1
$1.35M Buy
33,185
+15,728
+90% +$642K 0.03% 687
2020
Q4
$790K Buy
17,457
+5,128
+42% +$232K 0.02% 762
2020
Q3
$436K Buy
+12,329
New +$436K 0.02% 863
2020
Q1
Sell
-30,702
Closed -$1.59M 1033
2019
Q4
$1.59M Buy
30,702
+12,915
+73% +$670K 0.07% 360
2019
Q3
$976K Buy
17,787
+11,001
+162% +$604K 0.03% 494
2019
Q2
$276K Buy
+6,786
New +$276K 0.01% 878
2018
Q2
Sell
-9,687
Closed -$482K 1015
2018
Q1
$482K Sell
9,687
-6,604
-41% -$329K 0.02% 571
2017
Q4
$878K Sell
16,291
-2,751
-14% -$148K 0.02% 393
2017
Q3
$1.1M Buy
19,042
+5,123
+37% +$297K 0.03% 343
2017
Q2
$687K Sell
13,919
-11,356
-45% -$560K 0.02% 455
2017
Q1
$1.1M Buy
25,275
+8,206
+48% +$356K 0.03% 339
2016
Q4
$836K Buy
17,069
+4,238
+33% +$208K 0.02% 430
2016
Q3
$614K Buy
+12,831
New +$614K 0.01% 612
2016
Q2
Sell
-4,911
Closed -$220K 1428
2016
Q1
$220K Buy
+4,911
New +$220K 0.01% 1226
2014
Q3
Sell
-6,759
Closed -$313K 1323
2014
Q2
$313K Sell
6,759
-3,894
-37% -$180K 0.01% 809
2014
Q1
$438K Buy
+10,653
New +$438K 0.02% 585